In this episode, we are joined by Internal Medicine PGY-3s and soon-to-be fellows Dr. Carrie Mahurin and Dr. Jen Bergeron. Together, they review the evidence for or against a broadened therapeutic role of SGLT2 Inhibitors beyond diabetes treatment, in light of new trials suggesting efficacy in heart failure and chronic kidney disease management.
Guests: Dr. Carrie Mahurin, MD, PGY3 at UVMMC, and Dr. Jen Bergeron, MD, PGY3 at UVMMC
Thumbnail by Kate Hliznitsova on Unsplash
Episode 10: The Power of Pulmonary Prehabilitation
Episode 9: Public Health & Physician Leadership in Crisis
Exclusive Feature: LCOM Faculty Spotlight
BONUS SEGMENT: LCOM Med Students Weighing In
Episode 8: Medical Education in the Time of COVID19
Episode 7: COVID19 - Present Understanding & Future Directions
Episode 6: Bugs, Drugs & Antibiotic Stewardship in Vermont
Episode 5: The Call to Patient Advocacy
Episode 4: Insider's Look at ACP
Episode 3: Straight from the Chiefs: IM Residency at UVM
Episode 2: Chronic Pain & Opioids
Episode 1: The Debate on USMLE Step 1
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive